The main objective of the Investment approach is to generate capital appreciation through investments in equities with a medium to long-term perspective.

Alpha (1Y) | Beta (1Y) | Standard Deviation (1Y) | % of +ve Months (SI) |
---|---|---|---|
13.48% | 0.55 | 17.86% | 59.62% |
Performance Table #
Trailing Returns (%) | 1m return | 3m return | 6m return | 1y return | 2y return | 3y return | 5y return | 10y return | Since inception return |
---|---|---|---|---|---|---|---|---|---|
Kotak AMC Pharma Fund | -1.81% | 4.62% | 12.59% | -4.12% | 19.01% | 18.68% | 16.31% | - | 13.20% |
NIFTY 50 TRI | -1.21% | -0.71% | 11.33% | -2.01% | 13.99% | 12.48% | 17.90% | - | 13.45% |
QRC Report Card *
Strategy | Category | Fund Manager | Date of Inception | Age Of PMS | Corpus (in Cr, approx) | Benchmark | Returns SI (CAGR) | Stocks In Portfolio | Sectors In Portfolio |
---|---|---|---|---|---|---|---|---|---|
Kotak AMC Pharma Fund | Multi Cap | Anshul Saigal | 20 September 2016 | 9Y 0M | 23 | NIFTY 50 TRI | 13.20% | 5 | 19 |
Portfolio Quality (Q) | Portfolio Risk (R) | Portfolio Consistency (C) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Index | Category Alpha (1Y) | Relative Alpha (1Y) |
% of +ve Months
(Fund Data) |
Alpha (1Y) | Beta (1Y) |
Standard Deviation (1Y)
(Fund Data) |
Sharpe Ratio (1Y)
(Fund Data) |
Alpha (SI) | Information Ratio (SI) | Consistency Ratio % |
Nifty 50 | 9.68% | -7.16% | 59.62% | 2.52% | 0.92 | 17.86% | 0.37 | 0.53% | 0.03 | 50.00 % |
Nifty 500 | 10.23% | -4.98% | 5.25% | 0.87 | -0.16% | -0.01 | 49.04 % | |||
Nifty Midcap 100 | 5.14% | -1.37% | 3.77% | 0.74 | -2.36% | -0.13 | 47.12 % | |||
Nifty Smallcap 100 | 10.83% | 2.65% | 13.48% | 0.55 | 1.23% | 0.06 | 47.12 % |
VIEW DETAILED QUALITY, RISK, CONSISTENCY ANALYSIS
Portfolio Holdings
Holding | % |
---|
Sector Allocation
Holding | % |
---|---|
PHARMA & BIOTECH | 5.62 |
PHARMA & BIOTECH | 1.17 |
PHARMA & BIOTECH | 16.46 |
PHARMA & BIOTECH | 12.45 |
HEALTHCARE SERVICES | 7.63 |
PHARMA & BIOTECH | 2.99 |
PHARMA & BIOTECH | 6.08 |
HEALTHCARE SERVICES | 3.20 |
PHARMA & BIOTECH | 5.71 |
PHARMA & BIOTECH | 3.56 |
HEALTHCARE SERVICES | 5.37 |
PHARMA & BIOTECH | 3.80 |
PHARMA & BIOTECH | 3.18 |
PHARMA & BIOTECH | 6.08 |
PHARMA & BIOTECH | 4.27 |
PHARMA & BIOTECH | 1.69 |
PHARMA & BIOTECH | 3.01 |
PHARMA & BIOTECH | 3.93 |
PHARMA & BIOTECH | 2.72 |
Market Cap Allocation
Allocations | % |
---|---|
Large Cap | 16.30 |
Mid Cap | 24.60 |
Small Cap | 50.10 |
Cash | 9.00 |
Do Not Simply Invest, Make Informed Decisions
WISH TO MAKE INFORMED INVESTMENTS FOR LONG TERM WEALTH CREATION

Disclaimer
#Returns as of 31 Aug 2025. Returns up to 1 Year are absolute, above 1 Year are CAGR.
*QRC Report Card data is updated quarterly. Current data is as of Apr 25.